DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Cognetix explored the use of snail toxins for the treatment of epilepsy, pain and anesthesia.
Salt Lake City, UT
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.